The Dry Eye Society is proud to partner with Ophthalmopro in advancing the treatment of dry eye disease. Ophthalmopro’s Eye-light machine represents a significant innovation in dry eye management, combining Intense Pulsed Light (IPL) therapy and Low-Level Light Therapy (LLLT) to address the root causes of dry eye. This cutting-edge technology works to reduce inflammation, improve meibomian gland function, and enhance tear production, providing patients with long-lasting relief.

With its non-invasive approach, the Eye-light machine offers a promising solution for those suffering from dry eye disease, and the Dry Eye Society supports its role in improving patient outcomes through this revolutionary treatment.

Good Optical Services is dedicated to providing exceptional care and effective solutions for individuals managing dry eye disease.

As proud supporters of the Dry Eye Society, they offer a wide range of advanced products designed to alleviate the symptoms of dry eyes. Their selection includes lubricating eye drops and advanced therapeutic treatments focused on improving tear production and restoring ocular comfort. Some of their innovative solutions include ZEST, Eyes are the Story, Ocusoft and more.

With a commitment to personalised care and the latest dry eye management technologies, Good Optical Services strives to enhance the quality of life for those living with dry eye disease.

CSL Seqirus is a proud supporter of the Dry Eye Society, committed to enhancing the lives of those living with dry eye disease.

They offer innovative solutions like Ikervis, a cyclosporin-based treatment that addresses inflammation and helps manage severe keratitis in dry eye disease, and Cationorm, a preservative-free lubricant eye drop that restores moisture, stabilises the tear film, and protects the ocular surface.

Together, these therapies provide a holistic approach to alleviating symptoms and improving eye health for patients with dry eye disease.

Sun Pharma is a global leader in pharmaceutical innovation and a proud sponsor of the Dry Eye Society, sharing a commitment to advancing care for individuals with dry eye disease.

Their groundbreaking therapy, Cequa (cyclosporin ophthalmic solution), combines anti-inflammatory action technology to deliver effective dry eye relief. Designed to increase tear production and protect ocular health, Cequa offers renewed comfort and clarity for patients.

Together with the Dry Eye Society, Sun Pharma is dedicated to improving lives through innovation and advocacy in eye care.

The Dry Eye Societyis grateful for the support of InMode as a proud sponsor in the ongoing advancement of dry eye care. InMode’s innovative Envision device combines Radio Frequency (RF) and Intense Pulsed Light (IPL) technologies to effectively treat dry eye disease. By stimulating collagen and improving the structures responsible for producing oils in the tear film, Envision treats meibomian gland dysfunction by specifically targeting both the upper and lower eyelids. This non-invasive treatment directly stimulates the meibomian glands, helping to restore tear film stability and provide lasting relief.

InMode plays a crucial role in improving the lives of those affected by dry eye disease.